Literature DB >> 30508872

[Honest, Open, Proud: Concept and Efficacy of a peer-led Program to Provide Support with Disclosure Decisions and Coping with Stigma].

Nicolas Rüsch1, Nathalie Oexle1, Lea Reichhardt1, Stephanie Ventling2.   

Abstract

BACKGROUND: Due to the stigma associated with mental disorders, many people with mental illness face the difficult choice whether to disclose their illness to others. (Non-)Disclosure is a key reaction in coping with stigma. Disclosure as well as non-disclosure have risks and benefits, depending on the environment and the individual.
METHODS: "Honest, Open, Proud" (HOP; German: "In Würde zu sich stehen"/IWS) is a peer-led group program to support people with mental illness in their disclosure decisions. It is not HOP's aim to make participants disclose, but to support a well-informed and empowered decision.
RESULTS: Currently three RCTs, with several others underway, show HOP's positive effects in terms of reductions in stigma stress, disclosure distress, self-stigma, or depressive symptoms. Adolescent participants reported better quality of life, recovery, and attitudes to help-seeking. Adaptations for different diagnoses and age groups have been developed.
CONCLUSIONS: HOP appears to be a feasible and effective program to support people with mental illness in their disclosure decisions and in their coping with stigma. Future developments and public health implications are discussed. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30508872     DOI: 10.1055/a-0800-3695

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  2 in total

1.  [Focus on the stigma of mental disease].

Authors:  Georg Schomerus; Steffi Riedel-Heller
Journal:  Nervenarzt       Date:  2020-09       Impact factor: 1.214

Review 2.  Honest, Open, Proud to support disclosure decisions and to decrease stigma's impact among people with mental illness: conceptual review and meta-analysis of program efficacy.

Authors:  Nicolas Rüsch; Markus Kösters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-04-24       Impact factor: 4.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.